Latest News about edit
Recent news which mentions edit
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
From Benzinga
Editas Suddenly Terminates Chief Medical Officer Without An Explanation
February 08, 2022
Tickers
EDIT
From Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
February 08, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
From Benzinga
From InvestorPlace
21 Stocks Moving in Tuesday's Pre-Market Session
February 08, 2022
From Benzinga
2 Biotech Stocks That Could Skyrocket This Year
February 02, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Why Editas Medicine Stock Is Tumbling This Week
January 13, 2022
From Motley Fool
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
From InvestorPlace
NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today
December 13, 2021
From InvestorPlace
From InvestorPlace
EDIT Stock: The Preclinical Data Sending Editas Medicine Rallying Today
December 13, 2021
From InvestorPlace
22 Stocks Moving in Monday's Pre-Market Session
December 13, 2021
From Benzinga
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
December 08, 2021
From Motley Fool
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
Ocugen Stock: Bull vs. Bear
November 20, 2021
From Motley Fool
Editas Medicine, Inc (EDIT) Q3 2021 Earnings Call Transcript
November 08, 2021
Tickers
EDIT
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Should You Scoop Up Shares of This Promising Biotech on the Dip?
October 28, 2021
Tickers
EDIT
From Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.